1
|
Zhang L, Chen F, Xu L, Li N, Zhuo Q, Guo Y, Wang X, Wen M, Zhao Z, Li M. Comprehensive review of solid tumor bone marrow metastasis. Crit Rev Oncol Hematol 2024; 194:104248. [PMID: 38145832 DOI: 10.1016/j.critrevonc.2023.104248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2023] [Revised: 12/03/2023] [Accepted: 12/20/2023] [Indexed: 12/27/2023] Open
Abstract
Bone marrow metastasis (BMM) of solid tumors refers to a group of diseases that originate from non-hematopoietic malignant tumor cells invading the bone marrow (BM) through complex metastatic patterns. If BMM identification is delayed, the disease will rapidly develop into disseminated carcinogenesis of the BM, which manifests as a series of hematological disorders and microangiopathic hemolytic anemia, leading to serious life-threatening conditions. Although the study of solid tumor BMM is receiving increasing attention, study remains limited, and most descriptions are derived from case reports. Currently, clinicians have insufficient understanding of BMM, and BMM occurrence is often not recognized early or treated effectively, resulting in high mortality rates. In this article, we review the epidemiology, molecular mechanisms, clinical diagnosis, treatment, and prognosis of solid tumor BMM.
Collapse
Affiliation(s)
- Lanxin Zhang
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
| | - Fengxi Chen
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
| | - Lingzhi Xu
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
| | - Ning Li
- Dalian Medical University, Dalian, Liaoning, China
| | - Qiping Zhuo
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
| | - Yijin Guo
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
| | - Xueqing Wang
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
| | - Meijie Wen
- Department of Anesthesia & Operating Theater, China-Japan Friendship Hospital, Beijing, China
| | - Zuowei Zhao
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China; Department of Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
| | - Man Li
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
| |
Collapse
|
2
|
Prognostic Bone Metastasis-Associated Immune-Related Genes Regulated by Transcription Factors in Mesothelioma. BIOMED RESEARCH INTERNATIONAL 2022; 2022:9940566. [PMID: 35127947 PMCID: PMC8813231 DOI: 10.1155/2022/9940566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Revised: 09/30/2021] [Accepted: 11/30/2021] [Indexed: 11/17/2022]
Abstract
Mesothelioma (MESO) is a mesothelial originate neoplasm with high morbidity and mortality. Despite advancement in technology, early diagnosis still lacks effectivity and is full of pitfalls. Approaches of cancer diagnosis and therapy utilizing immune biomarkers and transcription factors (TFs) have attracted more and more attention. But the molecular mechanism of these features in MESO bone metastasis has not been thoroughly studied. Utilizing high-throughput genome sequencing data and lists of specific gene subsets, we performed several data mining algorithm. Single-sample Gene Set Enrichment Analysis (ssGSEA) was applied to identify downstream immune cells. Potential pathways involved in MESO bone metastasis were identified using Gene Oncology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, Gene Set Variation Analysis (GSVA), Gene Set Enrichment Analysis (GSEA), and Cox regression analysis. Ultimately, a model to help early diagnosis and to predict prognosis was constructed based on differentially expressed immune-related genes between bone metastatic and nonmetastatic MESO groups. In conclusion, immune-related gene SDC2, regulated by TFs TCF7L1 and POLR3D, had an important role on immune cell function and infiltration, providing novel biomarkers and therapeutic targets for metastatic MESO.
Collapse
|
3
|
Nishikubo M, Kin Y, Tane S, Nakamura K, Miyagi Y, Miura A, Nishio W, Senzaki H, Uchino K. Cellular cannibalism and consequent thrombocytopenia in a patient with bone marrow metastasis of malignant pleural mesothelioma: A case report. Mol Clin Oncol 2021; 15:163. [PMID: 34194741 PMCID: PMC8237155 DOI: 10.3892/mco.2021.2325] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2020] [Accepted: 05/07/2021] [Indexed: 11/24/2022] Open
Abstract
Cellular cannibalism is a tumor activity where a cell is engulfed by another cell. This process promotes tumor cell survival under unfavorable conditions. The current report describes an extremely rare case of thrombocytopenia resulting from cellular cannibalism in a patient with bone marrow metastasis due to malignant pleural mesothelioma (MPM). A 77-year-old male presented with hemothorax and thrombocytopenia. He was diagnosed with MPM of the sarcomatoid cell type. However, his disease progressed rapidly and he died 11 days after admission. Bone marrow aspiration revealed metastatic MPM cells that had engulfed other blood cells. Accordingly, the observed thrombocytopenia was attributed to cellular cannibalism by metastatic MPM tumor cells. To the best of our knowledge, this is the first reported case of thrombocytopenia due to cellular cannibalism in a patient with this type of malignancy (MPM). The results suggested that although MPM rarely metastasizes to the bone marrow, bone marrow aspiration could be useful in such cases.
Collapse
Affiliation(s)
- Megumi Nishikubo
- Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, Shibata, Kita-ku, Osaka 530-0012, Japan.,Division of Chest Surgery, Hyogo Cancer Center, Kitaouji-cho, Akashi 673-8558, Japan
| | - Yasuo Kin
- Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, Shibata, Kita-ku, Osaka 530-0012, Japan
| | - Shinya Tane
- Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, Shibata, Kita-ku, Osaka 530-0012, Japan.,Division of Chest Surgery, Hyogo Cancer Center, Kitaouji-cho, Akashi 673-8558, Japan
| | - Koji Nakamura
- Department of Clinical Laboratory Medicine, Osaka Saiseikai Nakatsu Hospital, Shibata, Kita-ku, Osaka 530-0012, Japan
| | - Yoshimi Miyagi
- Division of Pathology, Osaka Saiseikai Nakatsu Hospital, Shibata, Kita-ku, Osaka 530-0012, Japan
| | - Akiko Miura
- Department of Hematology, Osaka Saiseikai Nakatsu Hospital, Shibata, Kita-ku, Osaka 530-0012, Japan
| | - Wataru Nishio
- Division of Chest Surgery, Hyogo Cancer Center, Kitaouji-cho, Akashi 673-8558, Japan
| | - Hideto Senzaki
- Division of Pathology, Osaka Saiseikai Nakatsu Hospital, Shibata, Kita-ku, Osaka 530-0012, Japan
| | - Kazuya Uchino
- Department of General Thoracic Surgery, Osaka Saiseikai Nakatsu Hospital, Shibata, Kita-ku, Osaka 530-0012, Japan
| |
Collapse
|
4
|
Brown M, Jersmann H, Crowhurst T, Van Vliet C, Crouch G, Badiei A. A challenging diagnosis of malignant mesothelioma with osteosarcomatous differentiation metastasizing to bone. Respirol Case Rep 2020; 8:e00664. [PMID: 32995012 PMCID: PMC7507382 DOI: 10.1002/rcr2.664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 08/24/2020] [Accepted: 09/03/2020] [Indexed: 11/29/2022] Open
Abstract
Malignant pleural mesothelioma (MPM) is an insidious primary neoplasm of the pleura that can be challenging to diagnose and is commonly considered to be only locally invasive. We present the case of a 74-year-old male who presented with clinical features of MPM but from whom pleural fluid and biopsies initially suggested benign pathology. He later developed diffuse bony metastases and re-examination of pleural biopsies using modern immunohistochemistry and molecular testing revealed a diagnosis of sarcomatoid and desmoplastic MPM with heterologous osteosarcomatous differentiation. This case not only demonstrates the rare potential of skeletal metastasis of MPM, but also highlights the importance of recognizing the utility of modern diagnostic tests and their potential to prevent the need for unnecessary invasive procedures. To our knowledge this is the first description of this rare histological sub-type presenting with skeletal metastases.
Collapse
Affiliation(s)
- Michael Brown
- Department of Thoracic MedicineRoyal Adelaide HospitalAdelaideAustralia
- Faculty of Health and Medical Sciences, Adelaide Medical SchoolUniversity of AdelaideAdelaideAustralia
| | - Hubertus Jersmann
- Department of Thoracic MedicineRoyal Adelaide HospitalAdelaideAustralia
- Faculty of Health and Medical Sciences, Adelaide Medical SchoolUniversity of AdelaideAdelaideAustralia
| | - Thomas Crowhurst
- Department of Thoracic MedicineRoyal Adelaide HospitalAdelaideAustralia
- Faculty of Health and Medical Sciences, Adelaide Medical SchoolUniversity of AdelaideAdelaideAustralia
| | - Chris Van Vliet
- Department of Anatomical PathologyPathWest Laboratory Medicine, QEII Medical CentreNedlandsWestern AustraliaAustralia
| | - Gareth Crouch
- Department of Cardiothoracic SurgeryRoyal Adelaide HospitalAdelaideAustralia
| | - Arash Badiei
- Department of Thoracic MedicineRoyal Adelaide HospitalAdelaideAustralia
- Faculty of Health and Medical Sciences, Adelaide Medical SchoolUniversity of AdelaideAdelaideAustralia
| |
Collapse
|